Amgen Inc.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

19.81%

Market Cap

164.69 Bil.

P/E Ratio

23.01

Dividend Yield

2.91 %

Earnings per Share

12.61 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE305.15 G0 Units
PRICE DETERMINATION TIME06/23/2026 / 09:57:21 PM
DAILY VOLUME (UNITS)28
DAILY HIGH / LOW306.7301.85
PREV. DAY'S PRICE301.45 (06/22)
CHANGE DAY BEFORE
+3.70
1.23 %
52 WEEK HIGH / LOW333.25 (03/02)230.15 (09/17)
More Price Information

Key Figures (in EUR)

2027e2026e202520242023
EARNINGS PER SHARE20.6019.5712.616.9911.55
DIVIDENDS PER SHARE9.288.798.448.327.88
DIVIDEND YIELD IN %--2.91 %3.45 %2.96 %
DIVIDEND GROWTH IN %--1.42 %5.58 %6.80 %
PRICE - EARNINGS RATIO14.2915.0423.0134.4823.07
PRICE - BOOK RATIO--20.3723.8124.74
PRICE - SALES RATIO--4.834.245.53
PRICE - CASH FLOW RATIO--17.8212.2718.29
Further Key Figures

Master Data

WKN
867900
ISIN
US0311621009
SYMBOL
AMG
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Amgen
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
539.71 Mil.
MARKET CAPITALISATION
164.69 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-0.12 %
3.10 %
0.45 %
7.03 %
19.81 %
44.37 %
49.64 %
8.03 %
HIGH304.50308.95308.95333.25333.25333.25333.25333.25
LOW290.55279.15274.10271.60230.15199.50173.86271.60
Dividend
per share

Company profile

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.